Valuation: Krka, d. d.

Market Cap 7.87B 9.19B 7.37B 6.74B 12.65B 879B 12.82B 87.02B 33.94B 442B 34.51B 33.76B 1,461B P/E 2026 *
18.7x
P/E 2027 * 17.9x
Enterprise Value 7.2B 8.41B 6.74B 6.17B 11.58B 804B 11.73B 79.62B 31.05B 404B 31.57B 30.88B 1,337B EV / Sales 2026 *
3.33x
EV / Sales 2027 * 3.13x
Free-Float
74.74%
Yield 2026 *
3.85%
Yield 2027 * 3.94%
1 day+0.19%
1 week+0.58%
Current month+0.19%
3 months+0.58%
6 months+6.56%
Current year+28.08%
1 week 258.5
Extreme 258.5
262
1 month 257
Extreme 257
264
Current year 202
Extreme 202
270
1 year 174
Extreme 174
270
3 years 100
Extreme 100
270
5 years 80
Extreme 80
270
10 years 48.01
Extreme 48.01
270
Manager TitleAgeSince
Chief Executive Officer 71 01/01/2005
Director of Finance/CFO - 01/01/2026
Chief Tech/Sci/R&D Officer - 01/03/2023
Director TitleAgeSince
Director/Board Member 59 01/01/2005
Director/Board Member 59 01/01/2005
Director/Board Member 73 01/01/2010
Change 5-day change 1-year change 3-year change Capi.($)
+0.19%+0.58%+30.98%+151.21% 9.19B
-0.08%-1.43%+15.87%+67.24% 47.71B
-3.21%+1.37%+51.19%+124.26% 40.3B
-0.40%-1.23%-10.08%+17.30% 12.09B
+1.11%-1.34%+13.27%+72.07% 11.68B
-0.39%-0.92%+20.49%+39.85% 7.57B
-1.35%+0.74%+47.38%-12.13% 7.24B
-0.64%-0.02%+19.65%+205.39% 6.84B
-5.36%-6.36%-38.04%+19.49% 5.42B
-0.51%-0.90%+37.95%+105.39% 4.75B
Average -1.06%-1.09%+18.87%+79.00% 15.28B
Weighted average by Cap. -1.13%-0.58%+24.51%+84.30%

Financials

2026 *2027 *
Net sales 2.16B 2.53B 2.02B 1.85B 3.48B 242B 3.52B 23.92B 9.33B 121B 9.48B 9.28B 401B 2.29B 2.67B 2.14B 1.96B 3.68B 256B 3.73B 25.32B 9.88B 129B 10.04B 9.82B 425B
Net income 427M 498M 399M 365M 686M 47.65B 695M 4.72B 1.84B 23.94B 1.87B 1.83B 79.18B 449M 524M 420M 384M 721M 50.11B 731M 4.96B 1.93B 25.17B 1.97B 1.92B 83.26B
Net Debt -670M -782M -627M -574M -1.08B -74.84B -1.09B -7.41B -2.89B -37.59B -2.94B -2.87B -124B -708M -826M -662M -606M -1.14B -79.05B -1.15B -7.82B -3.05B -39.71B -3.1B -3.03B -131B
Logo Krka, d. d.
Krka dd Novo Mesto is a Slovenia-based company engaged in the production of pharmaceutical preparations. The Company operates through four segments: Prescription Pharmaceuticals that includes medicines for the treatment of cardiovascular diseases, alimentary tract and metabolism and drugs for diseases of the central nervous system, among others; Non-prescription Products, providing vitamins and minerals, cough and cold products, analgesics, sore throat products, among others; Animal Health Products, which offers general anti-infectives and antiparasitics for animals; Health Resort and Tourist Services consisting of Spa resorts in Smarjeske Toplice, Dolenjske Toplice, Strunjan, Novo Mesto and Otocec. Krka dd Novo Mesto is a controlling company of the Krka Group that includes two subsidiaries in Slovenia, Terme Krka doo and Farma GRS doo, and over 20 subsidiaries abroad in such countries as Croatia, Germany, Sweden, Poland, Spain, United States, Ireland, among others.
Employees
13,300
Date Price Change Volume
21/08/26 €260.00 +0.19% 20,404
20/08/26 €259.50 -0.19% 4,789
19/08/26 €260.00 0.00% 4,098
18/08/26 €260.00 0.00% 5,820
17/08/26 €260.00 +0.58% 2,946
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
260.00EUR
Average target price
245.65EUR
Spread / Average Target
-5.52%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KRKG Stock